161 related articles for article (PubMed ID: 33227006)
1. Increasing secular trends in height and obesity in children with type 1 diabetes: JSGIT cohort.
Mochizuki M; Ito Y; Yokomichi H; Kikuchi T; Soneda S; Musha I; Anzou M; Kobayashi K; Matsuo K; Sugihara S; Sasaki N; Matsuura N; Amemiya S;
PLoS One; 2020; 15(11):e0242259. PubMed ID: 33227006
[TBL] [Abstract][Full Text] [Related]
2. The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes.
Phelan H; Clapin H; Bruns L; Cameron FJ; Cotterill AM; Couper JJ; Davis EA; Donaghue KC; Jefferies CA; King BR; Sinnott RO; Tham EB; Wales JK; Jones TW; Craig ME
Med J Aust; 2017 Feb; 206(3):121-125. PubMed ID: 28208043
[TBL] [Abstract][Full Text] [Related]
3. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
[TBL] [Abstract][Full Text] [Related]
4. Improvement in glycemic control through changes in insulin regimens: findings from a Japanese cohort of children and adolescents with type 1 diabetes.
Mochizuki M; Kikuchi T; Urakami T; Kikuchi N; Kawamura T; Yokomichi H; Hoshino T; Matsuura N; Sasaki N; Sugihara S; Amemiya S;
Pediatr Diabetes; 2017 Sep; 18(6):435-442. PubMed ID: 27460670
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
6. Body composition in children with type 1 diabetes in the first year after diagnosis: relationship to glycaemic control and cardiovascular risk.
Davis NL; Bursell JD; Evans WD; Warner JT; Gregory JW
Arch Dis Child; 2012 Apr; 97(4):312-5. PubMed ID: 22294667
[TBL] [Abstract][Full Text] [Related]
7. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
[TBL] [Abstract][Full Text] [Related]
8. Status and trends in the use of insulin analogs, insulin delivery systems and their association with glycemic control: comparison of the two consecutive recent cohorts of Japanese children and adolescents with type 1 diabetes mellitus.
Yamamoto Y; Kikuchi T; Urakami T; Goto M; Tsubouchi K; Sasaki G; Mizuno H; Abe Y; Kitsuda K; Amemiya S; Sugihara S
J Pediatr Endocrinol Metab; 2019 Jan; 32(1):1-9. PubMed ID: 30517078
[TBL] [Abstract][Full Text] [Related]
9. Increased insulin requirement may contribute to risk of obesity in children and young people with Type 1 Diabetes Mellitus.
Apperley LJ; Ng SM
Diabetes Metab Syndr; 2019; 13(1):492-495. PubMed ID: 30641751
[TBL] [Abstract][Full Text] [Related]
10. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
[TBL] [Abstract][Full Text] [Related]
11. Choice of basal insulin therapy is associated with weight and height development in type 1 diabetes: A multicenter analysis from the German/Austrian DPV registry in 10 338 children and adolescents.
Vollbach H; Auzanneau M; Reinehr T; Wiegand S; Schwab KO; Oeverink R; Froehlich-Reiterer E; Woelfle J; De Beaufort C; Kapellen T; Gohlke B; Holl RW
J Diabetes; 2021 Nov; 13(11):930-939. PubMed ID: 34184423
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.
Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK
Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162
[TBL] [Abstract][Full Text] [Related]
13. Secular trends of body mass index in North Indian children with Type 1 diabetes do not support the Accelerator Hypothesis.
Dayal D; Samprathi M; Jayaraman D; Kohat D; Bhalla AK
Clin Endocrinol (Oxf); 2016 Mar; 84(3):338-41. PubMed ID: 26342175
[TBL] [Abstract][Full Text] [Related]
14. Five-year observation of the relationship between body mass index and glycated hemoglobin in children with Type 1 diabetes mellitus.
Kadłubiska A; Małachowska B; Noiszewska K; Fendler W; Głowińska-Olszewska B; Bossowski A; Łuczyński W
Scand J Clin Lab Invest; 2018 Sep; 78(5):398-406. PubMed ID: 29966439
[TBL] [Abstract][Full Text] [Related]
15. Development and linear growth in diabetic children receiving insulin pigment.
Mao L; Lu W; Ji F; Lv S
J Pediatr Endocrinol Metab; 2011; 24(7-8):433-6. PubMed ID: 21932577
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity.
Reinehr T; Holl RW; Roth CL; Wiesel T; Stachow R; Wabitsch M; Andler W;
Pediatr Diabetes; 2005 Mar; 6(1):5-12. PubMed ID: 15787895
[TBL] [Abstract][Full Text] [Related]
17. Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.
Konrad K; Datz N; Engelsberger I; Grulich-Henn J; Hoertenhuber T; Knauth B; Meissner T; Wiegand S; Woelfle J; Holl RW;
Pediatr Diabetes; 2015 Nov; 16(7):529-37. PubMed ID: 25131985
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus.
Kawamori R; Kadowaki T; Ishii H; Iwasaki M; Iwamoto Y
Diabetes Obes Metab; 2009 Sep; 11(9):891-9. PubMed ID: 19614947
[TBL] [Abstract][Full Text] [Related]
19. A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial.
Baskaran C; Volkening LK; Diaz M; Laffel LM
Pediatr Diabetes; 2015 Jun; 16(4):263-70. PubMed ID: 25039317
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
